CoChat

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients

Open access

The DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.

Abstract

BACKGROUND: LCP-Tacro is an extended-release formulation of tacrolimus designed for once-daily dosing. Phase 1 studies demonstrated greater bioavailability to twice-daily tacrolimus capsules and no new safety concerns. METHODS: In this phase 2 study, adult stable kidney transplant patients on tacrolimus capsules (Prograf) twice-daily were converted to tacrolimus tablets (LCP-Tacro) once-daily; patients continued on LCP-Tacro once-daily for days 8 to 21; trough levels were to be maintained between 5 and 15 ng/mL; 24-hr pharmacokinetic assessments were done on days 7 (baseline pre-switch), 14, and 21. RESULTS: Forty-seven patients completed LCP-Tacro dosing per protocol. The mean conversion ratio was 0.71. Pharmacokinetic data demonstrated consistent exposure (AUC) at the lower conversion dose. C(max) (P = 0.0001), C(max)/C(min) ratio (P < 0.001), percent fluctuation (P < 0.0001), and swing (P = 0.0004) were significantly lower and T(max) significantly (P < 0.001) longer for LCP-Tacro versus Prograf. AUC24 and C(min) correlation coefficients after 7 and 14 days of therapy were 0.86 or more, demonstrating a robust correlation between LCP-Tacro tacrolimus exposure and trough levels. There were three serious adverse events; none were related to study drug and all were resolved. CONCLUSIONS: Stable kidney transplant patients can be safely converted from Prograf twice-daily to LCP-Tacro. The greater bioavailability of LCP-Tacro allows for once-daily dosing and similar (AUC) exposure at a dose approximately 30% less than the total daily dose of Prograf. LCP-Tacro displays flatter kinetics characterized by significantly lower peak-trough fluctuations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/tp.0b013e3182962cc1

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Patient disposition.
FIGURE 1 Patient disposition.CC BY-NC-ND · PubMed Central
FIGURE 2 Mean whole-blood tacrolimus concentration in patients on days 7, 14, and 21 versus time.
FIGURE 2 Mean whole-blood tacrolimus concentration in patients on days 7, 14, and 21 versus time.CC BY-NC-ND · PubMed Central
FIGURE 3 Study design.
FIGURE 3 Study design.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 104

Metadata

Authors
Gaber, A. O., Alloway, R. R., Bodziak, K., Kaplan, B., & Bunnapradist, S.
Affiliations
  • Houston Methodist (US)
  • Christ Hospital (US)
  • University of Oklahoma Health Sciences Center (US)
  • University of Illinois Chicago (US)
  • University of California, Los Angeles (US)
Corresponding author
Gaber, A. Osama
Venue
Transplantation
Published
2013-07-27
Volume
96
Issue
2
Pages
191-197
ISSN
0041-1337 (ISSN-L)
OpenAlex
W2089557861
Cited by
100
References
25
Citations by year
2026: 2 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 3 · 2021: 11 · 2020: 9 · 2019: 7 · 2018: 4 · 2017: 10 · 2016: 9 · 2015: 12 · 2014: 5
FWCI
6.34
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Transplantation (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Baylor University
  • University of Cincinnati
  • Veloxis Pharmaceuticals
  • University of Illinois at Urbana-Champaign
  • University of California, Los Angeles
  • Baylor University Medical Center
Topics
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
tacrolimus, sustained-release formulation, once-daily dosing, kidney transplant recipients, pharmacokinetics, bioavailability, trough concentration, immunosuppression
MeSH terms
Adult, Biological Availability, Capsules, Delayed-Action Preparations, Drug Administration Schedule, Female, Humans, Immunosuppressive Agents, Male, Middle Aged, Prospective Studies, Kidney Transplantation, Tacrolimus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients. https://app.cochat.ai/papers/10.1097/tp.0b013e3182962cc1
The paper
Gaber, A. O., Alloway, R. R., Bodziak, K., Kaplan, B., & Bunnapradist, S. (2013). Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients. Transplantation. https://doi.org/10.1097/tp.0b013e3182962cc1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.